Consistently, DIRAS3 and FOSB showed a trend of downregulation in MM patients relative to normal subjects (P < 0.001), whereas the other genes showed the opposite trend (P < 0.001) (Figure 12). This evidence concerns the gene FOSB and Miyoshi myopathy.